NCAM1 and acute myeloid leukemia: When comparing TIGIT expression between AML patients and healthy donors, no significant differences were found within NK cells (61.2 ± 19.9% vs. 50.4 ± 24.6%, respectively) or CD56+ T cells (45.1 ± 21.1% vs. 36.9 ± 19.9%, respectively).